Gentamicin in pharmacogenetic approach to treatment of cystic fibrosis.
Hamilton
J W
JW
Center for Environmental Health Sciences at Dartmouth, Dartmouth Toxic Metals Research Program, Dartmouth Medical School, 03755, Hanover, NH, USA. josh.hamilton@dartmouth.edu
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D010597:Pharmacogenetics; D010641:Phenotype
D000900:Anti-Bacterial Agents; C505032:CFTR protein, human; D005839:Gentamicins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator